Keyphrases
Acetylcholine Receptor Antibody
11%
Acute Attack
9%
Aquaporin-4 (AQP4)
10%
Aquaporin-4 IgG
13%
Bent Spine
10%
BNT162b2 COVID-19 Vaccine
16%
Bradykinesia
9%
Brain Lesions
12%
Camptocormia
10%
Cervical Spinal Cord
9%
Clinical Characteristics
10%
Clinical Course
10%
Corticosteroid Treatment
9%
Demyelinating
10%
Diagnostic Criteria
9%
Disease Activity
22%
Disease Course
18%
Idiopathic Parkinson's Disease
19%
Intravenous Immunoglobulin (IVIg)
30%
Intravenous Immunoglobulin Therapy
22%
Israel
18%
Israeli
18%
Knee
18%
Lumbar Puncture
12%
Methylprednisolone
20%
Multicenter Cohort Study
9%
Multiple Sclerosis
92%
Multiple Sclerosis Treatment
19%
Myasthenia Gravis
49%
Myelin Oligodendrocyte Glycoprotein
22%
Myelin Oligodendrocyte Glycoprotein Antibody
9%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
61%
Myelin Oligodendrocyte Glycoprotein IgG
16%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
41%
Obesity
16%
Oligoclonal Bands
16%
Optic Neuritis
100%
Optical Coherence Tomography
15%
Parkinson's Disease
39%
Presenting Symptoms
13%
Response to Treatment
9%
Rest Tremor
15%
Retinal Nerve Fiber Layer
9%
Retinal Nerve Fiber Layer Thickness (RNFLT)
13%
Spinal Cord Lesion
9%
Steroid Treatment
10%
Sudden Sensorineural Hearing Loss (SSNHL)
9%
Tremor
12%
Vaccination
15%
Visual Outcome
12%
Neuroscience
Aquaporin 4
28%
Aquaporin 4 Antibody
9%
Basal Ganglia
6%
Bradykinesia
6%
Brain Lesion
10%
Chlordiazepoxide
20%
Cognitive Function
8%
Comorbidity
10%
Creutzfeldt Jakob Disease
8%
Diabetes Insipidus
8%
Diagnosis of Parkinson's Disease
5%
Dyskinesia
10%
Dystonia
10%
Fingolimod
8%
Hematopoietic Cell
8%
Immunoglobulin G
9%
Immunotherapy
10%
Intravenous Immunoglobulin
40%
Light Chain
8%
Lumbar Puncture
8%
Magnetic Resonance Imaging
20%
Magnetic Resonance Imaging
9%
Mesenchymal Stem Cell
8%
Methylprednisolone
18%
Multiple Sclerosis
77%
Myasthenia gravis
32%
Myelin
8%
Myelin Oligodendrocyte Glycoprotein
84%
Myelitis
5%
Nerve Fiber
19%
Neuromyelitis Optica
37%
Neuropeptide
8%
Neurotransmitter
8%
Oligoclonal Band
16%
Oligodendrocyte
8%
Optic Neuritis
86%
Oxidopamine
8%
Paraparesis
8%
Parkinson's Disease
44%
Polyneuropathy
8%
Prednisone
13%
Sensorineural Hearing Loss
12%
Transverse Myelitis
5%
Tremor
18%
Vertebral Column
14%
Medicine and Dentistry
Apomorphine
8%
Aquaporin 4
8%
Aquaporin 4 Antibody
9%
Bone Marrow Mesenchymal Stem Cell
8%
Brain Pseudotumor
8%
Cellular Immunity
8%
Cerebrospinal Fluid
16%
Cervical Spinal Cord
9%
Chlordiazepoxide
16%
Cohort Analysis
8%
Comorbidity
10%
COVID-19 Vaccination
8%
COVID-19 Vaccine
8%
Demyelination
8%
Diagnostic Error
8%
Disease Activity
12%
Disease Course
16%
Diseases
41%
Dyskinesia
8%
Fingolimod
8%
Homozygote
8%
Humoral Immunity
8%
Immunoglobulin
8%
Intravenous Immunoglobulin Therapy
8%
Lower Leg
8%
Lower Limb
8%
Lumbar Puncture
10%
Magnetic Resonance Imaging
20%
Mesenchymal Stem Cell
8%
Messenger RNA
8%
Methylprednisolone
13%
Multiple Sclerosis
60%
Myasthenia gravis
16%
Myelin Oligodendrocyte Glycoprotein
24%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
25%
Neuromyelitis Optica
25%
Oligoclonal Band
17%
Optic Neuritis
57%
Optical Coherence Tomography
19%
Oxidopamine
8%
Parkinson's Disease
36%
Pleocytosis
8%
Prednisone
9%
Retinal Nerve Fiber Layer
19%
Retrospective Study
11%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Shy-Drager Syndrome
8%
Steroid Treatment
10%
Susac Syndrome
8%
Wolfram Syndrome
8%
